nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergonovine—ABCB1—Tamoxifen—pancreatic cancer	0.0922	0.133	CbGbCtD
Ergonovine—ABCB1—Gemcitabine—pancreatic cancer	0.0794	0.115	CbGbCtD
Ergonovine—ABCB1—Erlotinib—pancreatic cancer	0.0784	0.113	CbGbCtD
Ergonovine—ABCB1—Irinotecan—pancreatic cancer	0.0708	0.102	CbGbCtD
Ergonovine—CYP3A4—Tamoxifen—pancreatic cancer	0.0552	0.0797	CbGbCtD
Ergonovine—ABCB1—Docetaxel—pancreatic cancer	0.0519	0.0749	CbGbCtD
Ergonovine—ABCB1—Sunitinib—pancreatic cancer	0.0516	0.0745	CbGbCtD
Ergonovine—CYP3A4—Erlotinib—pancreatic cancer	0.047	0.0678	CbGbCtD
Ergonovine—CYP3A4—Irinotecan—pancreatic cancer	0.0424	0.0612	CbGbCtD
Ergonovine—ABCB1—Doxorubicin—pancreatic cancer	0.0387	0.0558	CbGbCtD
Ergonovine—CYP3A4—Docetaxel—pancreatic cancer	0.0311	0.0449	CbGbCtD
Ergonovine—CYP3A4—Sunitinib—pancreatic cancer	0.0309	0.0447	CbGbCtD
Ergonovine—CYP3A4—Doxorubicin—pancreatic cancer	0.0232	0.0334	CbGbCtD
Ergonovine—Arteriospasm coronary—Fluorouracil—pancreatic cancer	0.0186	0.0954	CcSEcCtD
Ergonovine—Gangrene—Gemcitabine—pancreatic cancer	0.0126	0.0645	CcSEcCtD
Ergonovine—Drug interaction—Tamoxifen—pancreatic cancer	0.0043	0.0221	CcSEcCtD
Ergonovine—Drug interaction—Erlotinib—pancreatic cancer	0.00425	0.0218	CcSEcCtD
Ergonovine—Cramps of lower extremities—Tamoxifen—pancreatic cancer	0.00366	0.0188	CcSEcCtD
Ergonovine—Pulmonary oedema—Sunitinib—pancreatic cancer	0.00304	0.0156	CcSEcCtD
Ergonovine—Drug interaction—Gemcitabine—pancreatic cancer	0.00295	0.0152	CcSEcCtD
Ergonovine—Nasal congestion—Sunitinib—pancreatic cancer	0.00272	0.014	CcSEcCtD
Ergonovine—Pulmonary oedema—Gemcitabine—pancreatic cancer	0.00244	0.0125	CcSEcCtD
Ergonovine—Thrombophlebitis—Irinotecan—pancreatic cancer	0.00236	0.0121	CcSEcCtD
Ergonovine—Thrombophlebitis—Fluorouracil—pancreatic cancer	0.00226	0.0116	CcSEcCtD
Ergonovine—Acute coronary syndrome—Tamoxifen—pancreatic cancer	0.0022	0.0113	CcSEcCtD
Ergonovine—Myocardial infarction—Tamoxifen—pancreatic cancer	0.00219	0.0112	CcSEcCtD
Ergonovine—Acute coronary syndrome—Erlotinib—pancreatic cancer	0.00218	0.0112	CcSEcCtD
Ergonovine—Myocardial infarction—Erlotinib—pancreatic cancer	0.00216	0.0111	CcSEcCtD
Ergonovine—Sweating—Tamoxifen—pancreatic cancer	0.00214	0.011	CcSEcCtD
Ergonovine—Drug interaction—Docetaxel—pancreatic cancer	0.0021	0.0108	CcSEcCtD
Ergonovine—Acute coronary syndrome—Sunitinib—pancreatic cancer	0.00188	0.00968	CcSEcCtD
Ergonovine—Ventricular arrhythmia—Epirubicin—pancreatic cancer	0.00177	0.0091	CcSEcCtD
Ergonovine—Bradycardia—Sunitinib—pancreatic cancer	0.00175	0.00897	CcSEcCtD
Ergonovine—Pulmonary oedema—Docetaxel—pancreatic cancer	0.00173	0.00889	CcSEcCtD
Ergonovine—Muscle spasms—Tamoxifen—pancreatic cancer	0.00168	0.00861	CcSEcCtD
Ergonovine—Ventricular arrhythmia—Doxorubicin—pancreatic cancer	0.00164	0.00842	CcSEcCtD
Ergonovine—Thrombophlebitis—Docetaxel—pancreatic cancer	0.00163	0.00838	CcSEcCtD
Ergonovine—Acute coronary syndrome—Irinotecan—pancreatic cancer	0.00155	0.00797	CcSEcCtD
Ergonovine—Myocardial infarction—Irinotecan—pancreatic cancer	0.00154	0.00793	CcSEcCtD
Ergonovine—Acute coronary syndrome—Gemcitabine—pancreatic cancer	0.00151	0.00776	CcSEcCtD
Ergonovine—Sweating—Irinotecan—pancreatic cancer	0.00151	0.00775	CcSEcCtD
Ergonovine—Hypertension—Tamoxifen—pancreatic cancer	0.00151	0.00773	CcSEcCtD
Ergonovine—Myocardial infarction—Gemcitabine—pancreatic cancer	0.0015	0.00772	CcSEcCtD
Ergonovine—Acute coronary syndrome—Fluorouracil—pancreatic cancer	0.00149	0.00763	CcSEcCtD
Ergonovine—Chest pain—Tamoxifen—pancreatic cancer	0.00148	0.00762	CcSEcCtD
Ergonovine—Myocardial infarction—Fluorouracil—pancreatic cancer	0.00148	0.00759	CcSEcCtD
Ergonovine—Sweating—Gemcitabine—pancreatic cancer	0.00147	0.00755	CcSEcCtD
Ergonovine—Chest pain—Erlotinib—pancreatic cancer	0.00147	0.00754	CcSEcCtD
Ergonovine—Haematuria—Gemcitabine—pancreatic cancer	0.00146	0.00751	CcSEcCtD
Ergonovine—Bradycardia—Irinotecan—pancreatic cancer	0.00144	0.00739	CcSEcCtD
Ergonovine—Muscle spasms—Sunitinib—pancreatic cancer	0.00144	0.00737	CcSEcCtD
Ergonovine—Shock—Erlotinib—pancreatic cancer	0.00139	0.00711	CcSEcCtD
Ergonovine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00138	0.00707	CcSEcCtD
Ergonovine—Hypertension—Sunitinib—pancreatic cancer	0.00129	0.00662	CcSEcCtD
Ergonovine—Chest pain—Sunitinib—pancreatic cancer	0.00127	0.00653	CcSEcCtD
Ergonovine—Dyspnoea—Tamoxifen—pancreatic cancer	0.00127	0.00652	CcSEcCtD
Ergonovine—Dyspnoea—Erlotinib—pancreatic cancer	0.00126	0.00645	CcSEcCtD
Ergonovine—Cramps of lower extremities—Epirubicin—pancreatic cancer	0.00121	0.00619	CcSEcCtD
Ergonovine—Shock—Sunitinib—pancreatic cancer	0.0012	0.00616	CcSEcCtD
Ergonovine—Muscle spasms—Irinotecan—pancreatic cancer	0.00118	0.00607	CcSEcCtD
Ergonovine—Pulmonary oedema—Epirubicin—pancreatic cancer	0.00117	0.006	CcSEcCtD
Ergonovine—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00116	0.00598	CcSEcCtD
Ergonovine—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00115	0.00591	CcSEcCtD
Ergonovine—Abdominal pain—Tamoxifen—pancreatic cancer	0.00112	0.00578	CcSEcCtD
Ergonovine—Cramps of lower extremities—Doxorubicin—pancreatic cancer	0.00112	0.00573	CcSEcCtD
Ergonovine—Abdominal pain—Erlotinib—pancreatic cancer	0.00111	0.00572	CcSEcCtD
Ergonovine—Vertigo—Irinotecan—pancreatic cancer	0.00111	0.00568	CcSEcCtD
Ergonovine—Thrombophlebitis—Epirubicin—pancreatic cancer	0.0011	0.00565	CcSEcCtD
Ergonovine—Dyspnoea—Sunitinib—pancreatic cancer	0.00109	0.00558	CcSEcCtD
Ergonovine—Pulmonary oedema—Doxorubicin—pancreatic cancer	0.00108	0.00555	CcSEcCtD
Ergonovine—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.00107	0.00551	CcSEcCtD
Ergonovine—Myocardial infarction—Docetaxel—pancreatic cancer	0.00107	0.00548	CcSEcCtD
Ergonovine—Hypertension—Irinotecan—pancreatic cancer	0.00106	0.00545	CcSEcCtD
Ergonovine—Hypertension—Gemcitabine—pancreatic cancer	0.00103	0.00531	CcSEcCtD
Ergonovine—Chest pain—Gemcitabine—pancreatic cancer	0.00102	0.00524	CcSEcCtD
Ergonovine—Thrombophlebitis—Doxorubicin—pancreatic cancer	0.00102	0.00523	CcSEcCtD
Ergonovine—Chest pain—Fluorouracil—pancreatic cancer	0.001	0.00515	CcSEcCtD
Ergonovine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000997	0.00512	CcSEcCtD
Ergonovine—Shock—Irinotecan—pancreatic cancer	0.000988	0.00507	CcSEcCtD
Ergonovine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000974	0.005	CcSEcCtD
Ergonovine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00097	0.00499	CcSEcCtD
Ergonovine—Abdominal pain—Sunitinib—pancreatic cancer	0.000963	0.00495	CcSEcCtD
Ergonovine—Diarrhoea—Erlotinib—pancreatic cancer	0.000963	0.00495	CcSEcCtD
Ergonovine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000945	0.00486	CcSEcCtD
Ergonovine—Dizziness—Tamoxifen—pancreatic cancer	0.000941	0.00483	CcSEcCtD
Ergonovine—Hypotension—Irinotecan—pancreatic cancer	0.000938	0.00482	CcSEcCtD
Ergonovine—Dizziness—Erlotinib—pancreatic cancer	0.000931	0.00478	CcSEcCtD
Ergonovine—Hypotension—Gemcitabine—pancreatic cancer	0.000914	0.00469	CcSEcCtD
Ergonovine—Vomiting—Tamoxifen—pancreatic cancer	0.000905	0.00465	CcSEcCtD
Ergonovine—Hypotension—Fluorouracil—pancreatic cancer	0.000898	0.00461	CcSEcCtD
Ergonovine—Vomiting—Erlotinib—pancreatic cancer	0.000895	0.0046	CcSEcCtD
Ergonovine—Dyspnoea—Irinotecan—pancreatic cancer	0.000895	0.0046	CcSEcCtD
Ergonovine—Headache—Tamoxifen—pancreatic cancer	0.000891	0.00458	CcSEcCtD
Ergonovine—Headache—Erlotinib—pancreatic cancer	0.000882	0.00453	CcSEcCtD
Ergonovine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000872	0.00448	CcSEcCtD
Ergonovine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000857	0.0044	CcSEcCtD
Ergonovine—Nausea—Tamoxifen—pancreatic cancer	0.000845	0.00434	CcSEcCtD
Ergonovine—Nausea—Erlotinib—pancreatic cancer	0.000836	0.0043	CcSEcCtD
Ergonovine—Diarrhoea—Sunitinib—pancreatic cancer	0.000834	0.00428	CcSEcCtD
Ergonovine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000821	0.00422	CcSEcCtD
Ergonovine—Muscle spasms—Docetaxel—pancreatic cancer	0.000817	0.0042	CcSEcCtD
Ergonovine—Dizziness—Sunitinib—pancreatic cancer	0.000806	0.00414	CcSEcCtD
Ergonovine—Abdominal pain—Irinotecan—pancreatic cancer	0.000794	0.00408	CcSEcCtD
Ergonovine—Vomiting—Sunitinib—pancreatic cancer	0.000775	0.00398	CcSEcCtD
Ergonovine—Headache—Sunitinib—pancreatic cancer	0.000763	0.00392	CcSEcCtD
Ergonovine—Palpitations—Docetaxel—pancreatic cancer	0.000751	0.00386	CcSEcCtD
Ergonovine—Hypertension—Docetaxel—pancreatic cancer	0.000734	0.00377	CcSEcCtD
Ergonovine—Chest pain—Docetaxel—pancreatic cancer	0.000724	0.00372	CcSEcCtD
Ergonovine—Nausea—Sunitinib—pancreatic cancer	0.000724	0.00372	CcSEcCtD
Ergonovine—Sweating—Epirubicin—pancreatic cancer	0.000704	0.00361	CcSEcCtD
Ergonovine—Haematuria—Epirubicin—pancreatic cancer	0.0007	0.00359	CcSEcCtD
Ergonovine—Diarrhoea—Irinotecan—pancreatic cancer	0.000687	0.00353	CcSEcCtD
Ergonovine—Shock—Docetaxel—pancreatic cancer	0.000683	0.00351	CcSEcCtD
Ergonovine—Bradycardia—Epirubicin—pancreatic cancer	0.000671	0.00345	CcSEcCtD
Ergonovine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000669	0.00344	CcSEcCtD
Ergonovine—Dizziness—Irinotecan—pancreatic cancer	0.000664	0.00341	CcSEcCtD
Ergonovine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000658	0.00338	CcSEcCtD
Ergonovine—Sweating—Doxorubicin—pancreatic cancer	0.000651	0.00334	CcSEcCtD
Ergonovine—Hypotension—Docetaxel—pancreatic cancer	0.000648	0.00333	CcSEcCtD
Ergonovine—Haematuria—Doxorubicin—pancreatic cancer	0.000647	0.00333	CcSEcCtD
Ergonovine—Vomiting—Irinotecan—pancreatic cancer	0.000638	0.00328	CcSEcCtD
Ergonovine—Dizziness—Fluorouracil—pancreatic cancer	0.000636	0.00327	CcSEcCtD
Ergonovine—Headache—Irinotecan—pancreatic cancer	0.000629	0.00323	CcSEcCtD
Ergonovine—Vomiting—Gemcitabine—pancreatic cancer	0.000622	0.00319	CcSEcCtD
Ergonovine—Bradycardia—Doxorubicin—pancreatic cancer	0.000621	0.00319	CcSEcCtD
Ergonovine—Dyspnoea—Docetaxel—pancreatic cancer	0.000619	0.00318	CcSEcCtD
Ergonovine—Tinnitus—Epirubicin—pancreatic cancer	0.000614	0.00316	CcSEcCtD
Ergonovine—Headache—Gemcitabine—pancreatic cancer	0.000613	0.00315	CcSEcCtD
Ergonovine—Vomiting—Fluorouracil—pancreatic cancer	0.000611	0.00314	CcSEcCtD
Ergonovine—Headache—Fluorouracil—pancreatic cancer	0.000602	0.00309	CcSEcCtD
Ergonovine—Nausea—Irinotecan—pancreatic cancer	0.000596	0.00306	CcSEcCtD
Ergonovine—Nausea—Gemcitabine—pancreatic cancer	0.000581	0.00298	CcSEcCtD
Ergonovine—Nausea—Fluorouracil—pancreatic cancer	0.000571	0.00293	CcSEcCtD
Ergonovine—Tinnitus—Doxorubicin—pancreatic cancer	0.000568	0.00292	CcSEcCtD
Ergonovine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000567	0.00291	CcSEcCtD
Ergonovine—Muscle spasms—Epirubicin—pancreatic cancer	0.000551	0.00283	CcSEcCtD
Ergonovine—Abdominal pain—Docetaxel—pancreatic cancer	0.000549	0.00282	CcSEcCtD
Ergonovine—Vertigo—Epirubicin—pancreatic cancer	0.000515	0.00265	CcSEcCtD
Ergonovine—Muscle spasms—Doxorubicin—pancreatic cancer	0.00051	0.00262	CcSEcCtD
Ergonovine—Palpitations—Epirubicin—pancreatic cancer	0.000507	0.0026	CcSEcCtD
Ergonovine—Hypertension—Epirubicin—pancreatic cancer	0.000495	0.00254	CcSEcCtD
Ergonovine—Chest pain—Epirubicin—pancreatic cancer	0.000488	0.00251	CcSEcCtD
Ergonovine—Vertigo—Doxorubicin—pancreatic cancer	0.000477	0.00245	CcSEcCtD
Ergonovine—Diarrhoea—Docetaxel—pancreatic cancer	0.000475	0.00244	CcSEcCtD
Ergonovine—Palpitations—Doxorubicin—pancreatic cancer	0.000469	0.00241	CcSEcCtD
Ergonovine—Shock—Epirubicin—pancreatic cancer	0.00046	0.00237	CcSEcCtD
Ergonovine—Dizziness—Docetaxel—pancreatic cancer	0.000459	0.00236	CcSEcCtD
Ergonovine—Hypertension—Doxorubicin—pancreatic cancer	0.000458	0.00235	CcSEcCtD
Ergonovine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000452	0.00232	CcSEcCtD
Ergonovine—Chest pain—Doxorubicin—pancreatic cancer	0.000452	0.00232	CcSEcCtD
Ergonovine—Vomiting—Docetaxel—pancreatic cancer	0.000441	0.00227	CcSEcCtD
Ergonovine—Hypotension—Epirubicin—pancreatic cancer	0.000437	0.00225	CcSEcCtD
Ergonovine—Headache—Docetaxel—pancreatic cancer	0.000435	0.00223	CcSEcCtD
Ergonovine—Shock—Doxorubicin—pancreatic cancer	0.000426	0.00219	CcSEcCtD
Ergonovine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000419	0.00215	CcSEcCtD
Ergonovine—Dyspnoea—Epirubicin—pancreatic cancer	0.000417	0.00214	CcSEcCtD
Ergonovine—Nausea—Docetaxel—pancreatic cancer	0.000412	0.00212	CcSEcCtD
Ergonovine—Hypotension—Doxorubicin—pancreatic cancer	0.000405	0.00208	CcSEcCtD
Ergonovine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000386	0.00198	CcSEcCtD
Ergonovine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000383	0.00197	CcSEcCtD
Ergonovine—Abdominal pain—Epirubicin—pancreatic cancer	0.00037	0.0019	CcSEcCtD
Ergonovine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000354	0.00182	CcSEcCtD
Ergonovine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000342	0.00176	CcSEcCtD
Ergonovine—Diarrhoea—Epirubicin—pancreatic cancer	0.00032	0.00165	CcSEcCtD
Ergonovine—Dizziness—Epirubicin—pancreatic cancer	0.00031	0.00159	CcSEcCtD
Ergonovine—Vomiting—Epirubicin—pancreatic cancer	0.000298	0.00153	CcSEcCtD
Ergonovine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000296	0.00152	CcSEcCtD
Ergonovine—Headache—Epirubicin—pancreatic cancer	0.000293	0.00151	CcSEcCtD
Ergonovine—Dizziness—Doxorubicin—pancreatic cancer	0.000286	0.00147	CcSEcCtD
Ergonovine—Nausea—Epirubicin—pancreatic cancer	0.000278	0.00143	CcSEcCtD
Ergonovine—Vomiting—Doxorubicin—pancreatic cancer	0.000275	0.00141	CcSEcCtD
Ergonovine—Headache—Doxorubicin—pancreatic cancer	0.000271	0.00139	CcSEcCtD
Ergonovine—Nausea—Doxorubicin—pancreatic cancer	0.000257	0.00132	CcSEcCtD
Ergonovine—ADRA1A—Signaling Pathways—CCKBR—pancreatic cancer	7.73e-05	0.000686	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—AGTR1—pancreatic cancer	7.71e-05	0.000685	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—SST—pancreatic cancer	7.71e-05	0.000685	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	7.68e-05	0.000683	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—HES1—pancreatic cancer	7.63e-05	0.000678	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	7.59e-05	0.000674	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—GCG—pancreatic cancer	7.57e-05	0.000672	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	7.56e-05	0.000671	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SCT—pancreatic cancer	7.41e-05	0.000658	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HEY1—pancreatic cancer	7.41e-05	0.000658	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PRSS1—pancreatic cancer	7.37e-05	0.000654	CbGpPWpGaD
Ergonovine—ADRA1A—G alpha (q) signalling events—PIK3CA—pancreatic cancer	7.36e-05	0.000654	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—PIK3CB—pancreatic cancer	7.31e-05	0.000649	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—DTX4—pancreatic cancer	7.26e-05	0.000645	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GLI1—pancreatic cancer	7.26e-05	0.000645	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—AGTR1—pancreatic cancer	7.22e-05	0.000641	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	7.17e-05	0.000636	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	7.16e-05	0.000636	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CNR1—pancreatic cancer	7.11e-05	0.000632	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCK—pancreatic cancer	7.07e-05	0.000628	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NRP1—pancreatic cancer	7.07e-05	0.000628	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PPP2R5B—pancreatic cancer	7.07e-05	0.000628	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CXCL8—pancreatic cancer	7.02e-05	0.000624	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	7.02e-05	0.000623	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CNR2—pancreatic cancer	6.89e-05	0.000612	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—GLP1R—pancreatic cancer	6.89e-05	0.000612	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CXCL8—pancreatic cancer	6.88e-05	0.000611	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—GCG—pancreatic cancer	6.87e-05	0.00061	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	6.83e-05	0.000607	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HEY2—pancreatic cancer	6.8e-05	0.000604	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCKAR—pancreatic cancer	6.77e-05	0.000602	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	6.76e-05	0.000601	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TERT—pancreatic cancer	6.69e-05	0.000594	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GAST—pancreatic cancer	6.64e-05	0.00059	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	6.59e-05	0.000585	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	6.58e-05	0.000585	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—JAG2—pancreatic cancer	6.57e-05	0.000584	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—AGTR1—pancreatic cancer	6.55e-05	0.000582	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MEN1—pancreatic cancer	6.47e-05	0.000575	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—HIF1A—pancreatic cancer	6.39e-05	0.000568	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ARG2—pancreatic cancer	6.39e-05	0.000567	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TSC2—pancreatic cancer	6.38e-05	0.000566	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SCT—pancreatic cancer	6.3e-05	0.000559	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HEY1—pancreatic cancer	6.3e-05	0.000559	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—APOE—pancreatic cancer	6.24e-05	0.000554	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SHH—pancreatic cancer	6.18e-05	0.000549	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NOTCH4—pancreatic cancer	6.14e-05	0.000545	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—KDR—pancreatic cancer	6.11e-05	0.000543	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	6.11e-05	0.000543	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IAPP—pancreatic cancer	6.1e-05	0.000542	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	6.09e-05	0.000541	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCK—pancreatic cancer	6.01e-05	0.000534	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	5.95e-05	0.000529	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CNR2—pancreatic cancer	5.86e-05	0.00052	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PTHLH—pancreatic cancer	5.86e-05	0.00052	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PTCH1—pancreatic cancer	5.86e-05	0.00052	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GLP1R—pancreatic cancer	5.86e-05	0.00052	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CXCL8—pancreatic cancer	5.85e-05	0.00052	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—NFKBIA—pancreatic cancer	5.82e-05	0.000517	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCKAR—pancreatic cancer	5.76e-05	0.000512	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—NOTCH1—pancreatic cancer	5.76e-05	0.000512	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PIK3CG—pancreatic cancer	5.63e-05	0.0005	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—NRAS—pancreatic cancer	5.63e-05	0.0005	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—JAG2—pancreatic cancer	5.59e-05	0.000496	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—TYMP—pancreatic cancer	5.58e-05	0.000496	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—EGF—pancreatic cancer	5.57e-05	0.000495	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MEN1—pancreatic cancer	5.51e-05	0.000489	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	5.48e-05	0.000487	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	5.46e-05	0.000485	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	5.36e-05	0.000476	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SST—pancreatic cancer	5.36e-05	0.000476	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PIK3CG—pancreatic cancer	5.28e-05	0.000469	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SHH—pancreatic cancer	5.25e-05	0.000466	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—JAG1—pancreatic cancer	5.24e-05	0.000466	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NOTCH4—pancreatic cancer	5.22e-05	0.000464	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NOTCH3—pancreatic cancer	5.22e-05	0.000464	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IAPP—pancreatic cancer	5.19e-05	0.000461	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—EGFR—pancreatic cancer	5.13e-05	0.000456	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	5.1e-05	0.000453	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	5.06e-05	0.00045	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PTHLH—pancreatic cancer	4.98e-05	0.000442	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PTCH1—pancreatic cancer	4.98e-05	0.000442	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PIK3CD—pancreatic cancer	4.95e-05	0.00044	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CNR1—pancreatic cancer	4.94e-05	0.000439	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.9e-05	0.000436	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—KRAS—pancreatic cancer	4.85e-05	0.000431	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PIK3CG—pancreatic cancer	4.8e-05	0.000426	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—GCG—pancreatic cancer	4.77e-05	0.000424	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	4.65e-05	0.000413	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PIK3CD—pancreatic cancer	4.64e-05	0.000412	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AGTR1—pancreatic cancer	4.55e-05	0.000404	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SST—pancreatic cancer	4.55e-05	0.000404	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	4.54e-05	0.000403	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GLP1R—pancreatic cancer	4.5e-05	0.0004	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	4.5e-05	0.0004	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	4.49e-05	0.000399	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—STK11—pancreatic cancer	4.49e-05	0.000399	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—JAG1—pancreatic cancer	4.46e-05	0.000396	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—PIK3CA—pancreatic cancer	4.45e-05	0.000396	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NOTCH3—pancreatic cancer	4.44e-05	0.000394	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—DPYD—pancreatic cancer	4.43e-05	0.000393	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PIK3CB—pancreatic cancer	4.32e-05	0.000383	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PIK3CD—pancreatic cancer	4.22e-05	0.000375	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CNR1—pancreatic cancer	4.2e-05	0.000373	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	4.2e-05	0.000373	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CXCL8—pancreatic cancer	4.15e-05	0.000368	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—HRAS—pancreatic cancer	4.12e-05	0.000366	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3CG—pancreatic cancer	4.08e-05	0.000362	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GCG—pancreatic cancer	4.06e-05	0.00036	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.05e-05	0.000359	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—AKT1—pancreatic cancer	4.01e-05	0.000356	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CASP3—pancreatic cancer	3.97e-05	0.000353	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.95e-05	0.000351	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ARG2—pancreatic cancer	3.93e-05	0.000349	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SMAD4—pancreatic cancer	3.93e-05	0.000349	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CXCL8—pancreatic cancer	3.89e-05	0.000345	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AGTR1—pancreatic cancer	3.87e-05	0.000344	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCND1—pancreatic cancer	3.86e-05	0.000343	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HES1—pancreatic cancer	3.84e-05	0.000341	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CTNNB1—pancreatic cancer	3.83e-05	0.00034	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—STK11—pancreatic cancer	3.82e-05	0.000339	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.8e-05	0.000337	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MMP9—pancreatic cancer	3.75e-05	0.000333	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PTEN—pancreatic cancer	3.73e-05	0.000331	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PIK3CB—pancreatic cancer	3.68e-05	0.000326	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—AKT1—pancreatic cancer	3.64e-05	0.000323	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3CD—pancreatic cancer	3.59e-05	0.000318	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CXCL8—pancreatic cancer	3.53e-05	0.000314	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—SRC—pancreatic cancer	3.46e-05	0.000307	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.44e-05	0.000306	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—TYMP—pancreatic cancer	3.44e-05	0.000305	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—VEGFA—pancreatic cancer	3.37e-05	0.000299	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TERT—pancreatic cancer	3.36e-05	0.000299	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SMAD4—pancreatic cancer	3.34e-05	0.000297	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—STAT3—pancreatic cancer	3.34e-05	0.000296	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—NRAS—pancreatic cancer	3.33e-05	0.000296	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CXCL8—pancreatic cancer	3.31e-05	0.000294	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HES1—pancreatic cancer	3.26e-05	0.00029	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CD44—pancreatic cancer	3.25e-05	0.000289	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HIF1A—pancreatic cancer	3.22e-05	0.000286	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TSC2—pancreatic cancer	3.21e-05	0.000285	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—APOE—pancreatic cancer	3.14e-05	0.000279	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3CB—pancreatic cancer	3.13e-05	0.000278	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GCG—pancreatic cancer	3.12e-05	0.000277	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MYC—pancreatic cancer	3.1e-05	0.000275	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TGFB1—pancreatic cancer	3.09e-05	0.000275	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—KDR—pancreatic cancer	3.08e-05	0.000273	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—EGFR—pancreatic cancer	3.03e-05	0.000269	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CXCL8—pancreatic cancer	3e-05	0.000267	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—STK11—pancreatic cancer	2.93e-05	0.00026	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NFKBIA—pancreatic cancer	2.93e-05	0.00026	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NOTCH1—pancreatic cancer	2.9e-05	0.000257	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—KRAS—pancreatic cancer	2.86e-05	0.000254	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TERT—pancreatic cancer	2.86e-05	0.000254	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CG—pancreatic cancer	2.83e-05	0.000252	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—NRAS—pancreatic cancer	2.83e-05	0.000252	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EGF—pancreatic cancer	2.8e-05	0.000249	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	2.77e-05	0.000246	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HIF1A—pancreatic cancer	2.73e-05	0.000243	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TSC2—pancreatic cancer	2.73e-05	0.000242	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—DPYD—pancreatic cancer	2.73e-05	0.000242	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—APOE—pancreatic cancer	2.67e-05	0.000237	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PIK3CA—pancreatic cancer	2.63e-05	0.000234	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KDR—pancreatic cancer	2.62e-05	0.000232	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.59e-05	0.00023	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—EGFR—pancreatic cancer	2.58e-05	0.000229	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TP53—pancreatic cancer	2.55e-05	0.000226	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—TYMS—pancreatic cancer	2.52e-05	0.000224	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CD—pancreatic cancer	2.49e-05	0.000221	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NFKBIA—pancreatic cancer	2.49e-05	0.000221	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.47e-05	0.000219	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NOTCH1—pancreatic cancer	2.46e-05	0.000219	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—KRAS—pancreatic cancer	2.44e-05	0.000217	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—HRAS—pancreatic cancer	2.43e-05	0.000216	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CG—pancreatic cancer	2.41e-05	0.000214	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—NRAS—pancreatic cancer	2.41e-05	0.000214	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EGF—pancreatic cancer	2.38e-05	0.000212	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PIK3CA—pancreatic cancer	2.24e-05	0.000199	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—EGFR—pancreatic cancer	2.19e-05	0.000195	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CB—pancreatic cancer	2.17e-05	0.000193	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—AKT1—pancreatic cancer	2.15e-05	0.000191	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CD—pancreatic cancer	2.12e-05	0.000188	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.1e-05	0.000186	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CXCL8—pancreatic cancer	2.09e-05	0.000185	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—KRAS—pancreatic cancer	2.07e-05	0.000184	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—HRAS—pancreatic cancer	2.07e-05	0.000184	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—APOE—pancreatic cancer	2.05e-05	0.000182	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—AKT1—pancreatic cancer	2.02e-05	0.000179	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CD44—pancreatic cancer	2e-05	0.000178	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CASP3—pancreatic cancer	2e-05	0.000177	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCND1—pancreatic cancer	1.94e-05	0.000173	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CTNNB1—pancreatic cancer	1.92e-05	0.000171	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GCG—pancreatic cancer	1.92e-05	0.000171	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.91e-05	0.000169	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MMP9—pancreatic cancer	1.89e-05	0.000168	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PTEN—pancreatic cancer	1.88e-05	0.000167	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.85e-05	0.000164	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	1.85e-05	0.000164	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—AKT1—pancreatic cancer	1.83e-05	0.000163	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—STK11—pancreatic cancer	1.81e-05	0.00016	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PPARG—pancreatic cancer	1.79e-05	0.000159	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	1.77e-05	0.000158	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	1.76e-05	0.000157	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SRC—pancreatic cancer	1.74e-05	0.000155	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	1.71e-05	0.000152	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	1.7e-05	0.000151	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—VEGFA—pancreatic cancer	1.69e-05	0.000151	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—STAT3—pancreatic cancer	1.68e-05	0.000149	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NRAS—pancreatic cancer	1.67e-05	0.000149	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	1.65e-05	0.000147	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	1.64e-05	0.000145	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.63e-05	0.000145	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	1.6e-05	0.000143	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	1.6e-05	0.000142	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MYC—pancreatic cancer	1.56e-05	0.000138	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	1.56e-05	0.000138	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	1.56e-05	0.000138	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.55e-05	0.000138	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	1.52e-05	0.000135	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	1.48e-05	0.000131	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	1.44e-05	0.000128	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	1.44e-05	0.000128	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	1.43e-05	0.000127	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	1.42e-05	0.000126	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.42e-05	0.000126	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.41e-05	0.000125	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	1.33e-05	0.000118	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	1.32e-05	0.000118	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	1.32e-05	0.000117	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	1.3e-05	0.000115	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TP53—pancreatic cancer	1.28e-05	0.000114	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOE—pancreatic cancer	1.26e-05	0.000112	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PTEN—pancreatic cancer	1.23e-05	0.000109	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	1.22e-05	0.000109	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	1.22e-05	0.000109	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.14e-05	0.000101	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	1.13e-05	0.0001	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.1e-05	9.78e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	1.09e-05	9.67e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	1.08e-05	9.6e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	1.04e-05	9.25e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1e-05	8.91e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	9.19e-06	8.17e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	8.74e-06	7.76e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	8.66e-06	7.69e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	8.65e-06	7.68e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PTEN—pancreatic cancer	7.55e-06	6.71e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—AKT1—pancreatic cancer	7.06e-06	6.27e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	5.33e-06	4.73e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—AKT1—pancreatic cancer	4.35e-06	3.87e-05	CbGpPWpGaD
